Literature DB >> 2792780

Anaerobic bacteremia in the elderly.

M S Terpenning1.   

Abstract

Anaerobic bacteremia occurred in 68 patients over the age of 60 in a university hospital. These elderly patients were more likely than younger patients to have an underlying malignancy. Anaerobes involved included Bacteroides fragilis group (64 isolates), Bacteroides melaninogenicus group (11) and Clostridium species (11). Polymicrobial bacteremia was common, occurring in 32.3% of patients. Mortality in patients who had surgery to remove the source of anaerobes was 43.3%, compared to 81.7% in patients with no surgical treatment. Overall mortality was 66.1%, much higher than noted in younger populations.

Entities:  

Mesh:

Year:  1989        PMID: 2792780     DOI: 10.1159/000213011

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  5 in total

Review 1.  Bacteraemia in man and animals: an overview.

Authors:  J Vaid
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

2.  Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

Authors:  J Gómez; V Baños; J Ruiz; F Herrero; M Pérez; L Pretel; M Canteras; M Valdés
Journal:  Clin Investig       Date:  1993-08

3.  Anaerobic bacteremia: a retrospective four-year analysis in general medicine and cancer patients.

Authors:  R Kornowski; D Schwartz; M Averbuch; Y Levo; S Berger; M Giladi
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

4.  Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilis.

Authors:  B R Otto; W R Verweij; M Sparrius; A M Verweij-van Vught; C E Nord; D M MacLaren
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

5.  Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality.

Authors:  D Pittet; N Li; R P Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.